Amanote Research
Register
Sign In
Pmu26 - Budget Impact Analysis of Intravenous Biosimilars Compared With Intravenous Originators and Subcutaneous Products
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1862
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
Y Jang
A Byrne
F Toron
S Yoon
Publisher
Elsevier BV